Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse

Children with high-risk Hodgkin lymphoma were 10% less likely to relapse following treatment with brentuximab vedotin combination.

Developing ‘kinder’ treatments for a devastating childhood cancer

Breakthrough as new drug promises to shield child cancer patients from hearing loss

Study finds higher breast cancer risk after certain forms of childhood cancer treatment

Aggressive Cancer Cells Transformed Into Healthy Cells in Breakthrough

Cardiac RT May Amplify Late Disease Risk in Pediatric Cancer Survivors

Are Cannabis-Based Medicines Safe for Children With Cancer?

Homoharringtonine May be ‘Better Alternative’ to Etoposide In Pediatric AML

Researchers discover new therapeutic approach for neuroblastoma

Solving the Mystery of Long-Lasting Cancer Treatment – Scientists Reveal New Insights

The challenge of treating childhood brain cancers